Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise.
about
New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscleMetabolic adaptations to repeated periods of contraction with reduced blood flow in canine skeletal muscle.Modulation of extracellular matrix genes reflects the magnitude of physiological adaptation to aerobic exercise training in humansMalnutrition and Gut Flora Dysbiosis: Specific Therapies for Emerging Comorbidities in Heart FailureOxygen uptake on-kinetics in dog gastrocnemius in situ following activation of pyruvate dehydrogenase by dichloroacetateThe human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function.Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia.Muscle oxygen uptake in humans at onset of and during intense exercise.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Effects of respiratory alkalosis on human skeletal muscle metabolism at the onset of submaximal exercise.Variability in training-induced skeletal muscle adaptation.Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages.Metabolic inertia in contracting skeletal muscle: a novel approach for pharmacological intervention in peripheral vascular diseaseCarnitine Acetyltransferase Mitigates Metabolic Inertia and Muscle Fatigue during ExerciseValidation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS.Low intensity exercise in humans accelerates mitochondrial ATP production and pulmonary oxygen kinetics during subsequent more intense exercise.Effects of acetate infusion and hyperoxia on muscle substrate phosphorylation after onset of moderate exercise.Enhanced pyruvate dehydrogenase activity does not affect muscle O2 uptake at onset of intense exercise in humans.Skeletal muscle metabolism is unaffected by DCA infusion and hyperoxia after onset of intense aerobic exercise.The acetyl group deficit at the onset of contraction in ischaemic canine skeletal muscle.Carbohydrate ingestion reduces skeletal muscle acetylcarnitine availability but has no effect on substrate phosphorylation at the onset of exercise in man.A "Wearable" Test for Maximum Aerobic Power: Real-Time Analysis of a 60-m Sprint Performance and Heart Rate Off-Kinetics.Acetyl-CoA provision and the acetyl group deficit at the onset of contraction in ischemic canine skeletal muscle.Acetyl group availability influences phosphocreatine degradation even during intense muscle contraction.Mitochondrial activation at the onset of contractions in isolated myofibres during successive contractile periods.Systematic analysis of adaptations in aerobic capacity and submaximal energy metabolism provides a unique insight into determinants of human aerobic performance.No effect of glutamine supplementation and hyperoxia on oxidative metabolism and performance during high-intensity exercise.Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in chronic obstructive pulmonary disease.No acetyl group deficit is evident at the onset of exercise at 90% of maximal oxygen uptake in humans.Effect of type 2 diabetes on the dynamic response characteristics of leg vascular conductance during exercise.Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents.Limitations of skeletal muscle oxygen delivery and utilization during moderate-intensity exercise in moderately impaired patients with chronic heart failure.Negative regulation of HIF in skeletal muscle of elite endurance athletes: a tentative mechanism promoting oxidative metabolism.
P2860
Q24679531-7864BC31-EC78-4290-A656-1F58A6EEE08AQ24813903-9F7EBF5C-89DC-404C-BB9C-E59D88CABD64Q24815394-7B4E321E-4FED-4075-95C9-6800E2C8D9F4Q26780506-C11B7C28-70AA-4354-B096-D96AA9E70F06Q28344431-6A5C467D-47B0-4EEA-BC23-2AA8022EAEC2Q33278821-C7AAD516-7584-4806-BA00-A4FF00212B15Q33693709-245AE1EF-4DC5-4FA2-B5A5-D5EFA0831DCCQ33888448-FF512BDD-5548-405F-BE9F-E6139F8208F4Q33901722-2B7DEF45-4424-4DC6-B30C-A9AB55A2DA0CQ34152505-AFDDD96A-E553-4BC2-B011-2032942FEEC8Q34753853-6C1D356F-556E-4FD5-B35E-1C5B204291A4Q35663501-AE3DFBFC-2DD2-483A-85D7-3183252C31A6Q35681270-453E4031-4190-4732-BD10-5AB991EA8E16Q36581524-B2A6EA9C-A173-4A47-B9F7-4A806188700EQ42108807-E5B951B1-3BC9-4C20-A9F1-4DB06B6D2F8FQ42516818-E9FCF728-CC4A-463B-BCB4-21744C9EF379Q43794355-38780168-49FF-4D14-B63A-7526A30A03ECQ43822357-3BDBFE1A-32DD-4078-9D36-5E5F2992CEFCQ44030239-BADB1EE5-AA0B-46D9-9C9F-ECE67AF55D17Q44180923-4166F8E2-C9F1-4292-BABD-22637D2F6F83Q44201763-67CC09D9-F278-4689-9796-1D8C0CB87D1DQ44676555-58AA77EE-531F-428F-9E7E-544645235948Q45083273-36F633C8-7557-4B46-9FE4-77C9E27D869FQ45119258-EC46A626-82A5-473A-9B02-84B6A67FFD5FQ46009998-2D812BEC-CEF4-418E-8FEA-41602BA306EDQ46131585-4792CCCD-4D13-4E36-9642-7DDCFCE4E97FQ46496030-8F4DC2C5-FD3B-4DCC-89BB-0CF2E9A6679BQ46761839-4CA91DD7-5BC8-43F9-83B2-B52D77C1AEC9Q47621409-1DD6B0F9-DD1C-4268-A2BD-A47D8C1FA64DQ50528010-2D78959F-E79B-4176-A610-E9BBF6A88265Q51305299-E85D551C-4801-4CF6-928B-54CC9B0B5C5DQ51436909-C424F2D6-72D7-4F5B-916E-95338759D91DQ54347258-5566B25C-D069-4792-9256-A3BF40EBB21B
P2860
Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Substrate availability limits ...... he onset of ischemic exercise.
@en
Substrate availability limits ...... he onset of ischemic exercise.
@nl
type
label
Substrate availability limits ...... he onset of ischemic exercise.
@en
Substrate availability limits ...... he onset of ischemic exercise.
@nl
prefLabel
Substrate availability limits ...... he onset of ischemic exercise.
@en
Substrate availability limits ...... he onset of ischemic exercise.
@nl
P2093
P2860
P356
P1476
Substrate availability limits ...... he onset of ischemic exercise.
@en
P2093
Chwalbinska-Moneta J
Constantin-Teodosiu D
Greenhaff PL
Gustafsson T
Macdonald IA
Timmons JA
P2860
P356
10.1172/JCI1146
P407
P577
1998-01-01T00:00:00Z